GSTZ1 Haplotyping Test
Personalized dosing of Dichloroacetate (DCA) for various diseases
Developed (LDT)Active
Key Facts
Indication
Personalized dosing of Dichloroacetate (DCA) for various diseases
Phase
Developed (LDT)
Status
Active
Company
About Medosome Biotec
Medosome Biotec is a private, preclinical-stage biotech focused on addressing unmet needs in pediatric healthcare through precision medicine. Its core strategy involves developing companion diagnostics, such as genetic tests for rare disease diagnosis and pharmacogenomic-guided dosing, alongside therapeutic programs for conditions like white matter injury in infants. The company appears to be pre-revenue, leveraging scientific and entrepreneurial expertise to advance early-stage technologies from late discovery through IND/Phase I readiness.
View full company profile